SCHEMBL13544233

SCHEMBL13544233

COc1cc(-c2ccccc2)c2c(n1)NCC2C#N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 5/20 0.39
ALDH1A1 P00352 8/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 2/20 0.36
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
MAPT P10636 5/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
IKBKB O14920 1/20 0.33
CHUK O15111 1/20 0.33
KDM4E B2RXH2 4/20 0.32
GAA P10253 3/20 0.32
HPGD P15428 3/20 0.32
NPSR1 Q6W5P4 3/20 0.32
MITF O75030 1/20 0.32
LMNA P02545 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3568836 0.63 LRRK2 (0.67) IKBKBCHUK
SCHEMBL27517425 0.59 NPC1 (0.55) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL31232952 0.58 GABRP (0.43) SQORALDH1A1NPC1RAB9AMAPT
SCHEMBL5774657 0.58 SQOR (0.41) SQORALDH1A1NPC1RAB9AMAPT
SCHEMBL14570639 0.58 PRNP (0.57) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL12112651 0.58 ACACA (0.55) SQORALDH1A1NPC1RAB9AMAPT
SCHEMBL13996081 0.57 ALDH1A1 (0.51) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL22215650 0.57 SQOR (1.00) SQORALDH1A1NPC1MAPTKMT2A
SCHEMBL17054156 0.57 SQOR (0.44) SQORALDH1A1NPC1RAB9AMAPT
SCHEMBL1137721 0.57 KDM4E (0.44) SQORALDH1A1NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100010037-A1 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES USEFUL AS HSP90 INHIBITORS VERNALIS (R&D) LTD. (GB) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100010037-A1 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES USEFUL AS HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P SQOR 405/4885ALDH1A1 1315/4885NPC1 2260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.